ALEXIS LIPPS: Open Payments
NPI 1659002954 · BLUFFTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,232 in 54 payments from 29 companies in 2025. Trend: 2023 $1,413 · 2024 $1,120 · 2025 $1,232
Food & beverage: $1,232
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $157 |
| Novartis Pharmaceuticals Corporation | 6 | $132 |
| E.R. Squibb & Sons, L.L.C. | 4 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $74 |
| Stemline Therapeutics Inc. | 3 | $73 |
| Janssen Biotech, Inc. | 2 | $69 |
| Celgene Corporation | 3 | $67 |
| Daiichi Sankyo Inc. | 2 | $56 |
| SOBI, INC | 2 | $45 |
| ADC THERAPEUTICS AMERICA, INC. | 2 | $45 |
Products named: KEYTRUDA, Nubeqa, REBLOZYL, OPDIVO, Enhertu, Orserdu, Vonjo, ZYNLONTA.
Industry payments across SC — which companies pay providers there.
